Dr. Preston D. Steen
Claim this profileSanford Roger Maris Cancer Center
Expert in Lung Cancer
Expert in Breast Cancer
113 reported clinical trials
192 drugs studied
About Preston D. Steen
Education:
- Obtained MD from the University of North Dakota School of Medicine & Health Sciences (2015).
- Completed Residency in Internal Medicine at the University of Minnesota Medical Center (2018).
- Finished Fellowship in Hematology/Oncology at the Mayo Clinic, Rochester, Minnesota (2021).
Experience:
- Currently practices as a hematologist and oncologist at Sanford Roger Maris Cancer Center.
- Specializes in internal medicine, hematology, and oncology.
Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 positive
Stage IV
ER positive
Affiliated Hospitals
Clinical Trials Preston D. Steen is currently running
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting2 awards Phase 3
More about Preston D. Steen
Clinical Trial Related6 years of experience running clinical trials · Led 113 trials as a Principal Investigator · 36 Active Clinical TrialsTreatments Preston D. Steen has experience with
- Nivolumab
- Cisplatin
- Atezolizumab
- Carboplatin
- Pembrolizumab
- Ipilimumab
Breakdown of trials Preston D. Steen has run
Lung Cancer
Breast Cancer
Prostate Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Preston D. Steen specialize in?
Preston D. Steen focuses on Lung Cancer and Breast Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Preston D. Steen currently recruiting for clinical trials?
Yes, Preston D. Steen is currently recruiting for 36 clinical trials in Fargo North Dakota. If you're interested in participating, you should apply.
Are there any treatments that Preston D. Steen has studied deeply?
Yes, Preston D. Steen has studied treatments such as Nivolumab, Cisplatin, Atezolizumab.
What is the best way to schedule an appointment with Preston D. Steen?
Apply for one of the trials that Preston D. Steen is conducting.
What is the office address of Preston D. Steen?
The office of Preston D. Steen is located at: Sanford Roger Maris Cancer Center, Fargo, North Dakota 58122 United States. This is the address for their practice at the Sanford Roger Maris Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.